OBJECTIVES: Patients with obesity hypoventilation syndrome (OHS) have significant morbidity and mortality. Early diagnosis and treatment is important and there are limited data on its prevalence and predictive factors. The objective of this observational study was to determine the frequency and predictors of OHS in hospitalized patients at a tertiary health care institution.
A lveolar hypoventilation exists when the partial arterial carbon dioxide pressure (PaCO 2 ) is 45 mmHg or higher. The pathophysiology underlying hypoventilation can range from abnormal central respiratory drive, increased workload, mechanical failure, to abnormal mechanics or a combination of these conditions. [1] Obesity hypoventilation syndrome (OHS) is defined as the combined presence of obesity (body mass index [BMI] >30 kg/m 2 ) and daytime arterial hypercapnia (PaCO 2 >45 mmHg), in the absence of other causes of hypoventilation. [2, 3] Patients with OHS have a poor quality of life, more healthcare expenses, a greater risk of pulmonary hypertension and a higher mortality rate. It is often unrecognized and treatment is frequently delayed. [4] As the patients have significant morbidity and mortality, early diagnosis and treatment is important. In clinical practice, chronic obstructive pulmonary disease (COPD) is the most common cause of chronic hypoventilation. However, no studies are carried out on the following diseases and their prevalence. [5] The objective of this observational study was to determine the frequency and predictors of OHS in hospitalized patients at a tertiary health care institution.
Materials and Methods
This prospective and observational study was conducted at a tertiary care hospital and was approved by the hospital's ethics committee. All arterial blood gas analyses of hospitalized adult (age >18 years) patients were prospectively recruited from the biochemistry laboratory, each day from August 2009 to July 2010. Patients who had respiratory hypercapnia (PaCO 2 ≥45 mmHg) were asked to volunteer for the study. Abnormal blood gas results (PaCO 2 ≥45 mmHg) were re-tested during day-time while patients were awake at clinically stable condition. Arterial blood samples were drawn after a 10 min rest in a sitting position. Out-patients, patients with metabolic acidosis and those who did not give informed consent were excluded.
A standard questionnaire (including demographic data, patient history, previous diagnoses and drug use, etc.,) was filled by face-to-face interview with patients and/or relatives. Other clinical and laboratory data (physical exam findings and routine laboratory evaluations, pulmonary function tests, blood gases, prior and current diagnoses) were obtained from hospital records. Hypoventilation was defined as an arterial partial pressure of PaCO 2 ≥45 mmHg. Patients who have hypercapnia (PaCO 2 ≥45), a pH within normal range (pH = 7.36-7.44) and elevated HCO 3 − level following at least 3 weeks of stable disease were categorized as chronic hypoventilation. Causes of hypoventilation were determined according to the guideline by Subramanian and Strohl [ Figure 1] . [6] OHS was defined as obesity (BMI >30 kg/m 2 ) with awake hypoventilation in the absence of other known causes of hypoventilation (obstructive or restrictive parenchymal lung diseases, kyphoscoliosis, neuromuscular disorders and hypothyroidism). [2, 3] Diagnosis of asthma and COPD was determined according to the GOLD and GINA criteria. [7, 8] 
Statistical analysis
The Kolmogorov-Smirnov test was used to test for a normal distribution of continuous variables. Data characterized by a normal distribution were expressed as mean ± standard deviation. Parameters without such a distribution were expressed as a median with range. ANOVA and student's t-tests were used for the comparison of data which had a normal distribution. The Mann-Whitney-U and Kruskal-Wallis tests were used for the comparison of non-normally distributed data. Discrete variables were compared using the Chi-square test.
Factors that were potential predictors of OHS were analyzed using logistic regression. Multivariate logistic regression analysis was used as a stepwise descending method from predictive factors with significance ≤0.05 in the univariate analysis. Diagnostic accuracies of parameters for identifying OHS were assessed using the area under the receiver operating characteristic (ROC) curve area under curve (AUC). P < 0.05 were considered to be significant. Data were analyzed using SPSS statistical software (version 13.01, serial number 9069728, SPSS Inc., Chicago).
Results
During the period of study, a total of 9480 patients' arterial blood gases were evaluated and 330 patients (3.4%) that met the selection criteria were included in the analysis. Of patients with hypoventilation, 122 (37%) were female and the mean age was 62. 
Discussion
In current practice, hypoventilation is often used synonymously with hypercapnic respiratory failure. It is known that pulmonary and many extra-pulmonary pathological conditions lead to the development of hypoventilation. In our study, among the 9480 hospitalized patients, 330 patients (3.4%) were detected to have alveolar hypoventilation. Except in specific patients groups, the exact prevalence of hypoventilation in the general population is unknown. A study by Ray et al. demonstrated hypercapnia in 44 (9%) of the 514 emergency department patients with acute respiratory failure. [9] In a similar study conducted by Hussain [10] Perhaps because we used a different methodology in our study, we found lower rates of hypercapnia compared with these studies.
In clinical practice, COPD is the most common cause of chronic hypoventilation. [5] In our study, of patients with chronic hypoventilation, 63.6% were associated with chronic obstructive lung diseases. The rates of chronic hypercapnia in COPD patients are reported to a range from 60% to 70% respectively. [11, 12] The second most common cause of hypoventilation was OHS and was detected in 24.4% of our patients. The precise prevalence of OHS in the general population is unknown; however, it is estimated to be between 0.15% and 0.3% and some studies have reported the prevalence rates between 19% and 31% in obese patients. [13, 14] Patients with OHS have been reported to have the most severe arterial blood gas disturbances compared with the other chronic pulmonary groups and they exhibited the most severe nocturnal oxygen desaturations. [15] In our study, although we did not study nocturnal oxygenation, OHS cases had significantly lower daytime PaO 2 and SaO 2 levels. Furthermore, a SaO 2 <91.4% was found to be a significant predictor of OHS. Mokhlesi et al. in their study have reported the lowest oxygen saturation during sleep as an independent predictor of OHS in obstructive sleep apnea patients.
[4] They It is known that OHS and OSAS are often associated and the majority of patients with OHS have severe OSAS. [13] However, due to the methodological design of our study, the rate of OSAS could not be determined. Approximately, 80% of OHS cases have been shown to have OSAS in the literature. [3] On the contrary, the prevalence of OHS in patients with obstructive sleep apnea was found to be 30% in a retrospective random sample and 20% in a prospective sample by Mokhlesi et al. [4] In a meta-analysis including 4250 OSAS patients by Kaw et al., day-time hypercapnia was present in 788 patients (19%). [13] Laaban and Chailleux have reported the prevalence of day-time hypercapnia as 11% among 1141 OSAS patients. [16] However, in both study, day-time hypercapnia was related to the severity of obesity and obesity-related impairment in lung function. [13, 16] Whereas most patients with OHS have had prior hospitalizations and have higher healthcare utilization, the formal diagnosis of OHS is established late in the fifth or sixth decade of life. [17] The most common presentations of the patients are an acute-on-chronic exacerbation with acute respiratory acidosis leading to admission to an intensive care unit, or during a routine outpatient evaluation by a sleep specialist or pulmonologist. [17] Nowbar et al. in their study have reported that patients with OHS were mostly identified during systematic screening of hospitalized patients and that the vast majority were discharged from the hospital without any form of therapy for hypoventilation. [14] Therapy for hypoventilation at discharge was initiated in only 6 (13%) of patients with OHS. [14] Similarly, only 17.2% of OHS patients in our study had a formal diagnosis of OHS and the majority of the remaining OHS patients were mistakenly treated as COPD, heart failure or both.
There were some limitations of the present study. First, this study was performed in a specific patient group in a tertiary health care institution and may not represent OHS prevalence in the general population. However, we think our results are valuable since it provides information on causes of chronic alveolar hypoventilation in order of frequency. The second limitation is the lack of polysomnography testing in some patients (due to the observational design of the study) to clarify associated OSAS. We think the lack of polysomnographic examination does not influence our results since OSAS in non-obese patients is not expected to cause day-time hypercapnia. [13, 16, 18] 
Conclusion
Our study showed that the SaO 2 level and PaCO 2 /BMI ratio were strong predictors for OHS in obese hospitalized patients in a tertiary health care institution. Hypoventilation was observed in 3.4% of hospitalized patients who participated in the study. Of these patients, 35.8% had chronic alveolar hypoventilation that was mostly associated with chronic obstructive lung diseases and OHS. Because misdiagnoses are common among OHS patients, a careful examination of body mass index, SaO 2 level and particularly PaCO 2 /BMI ratio may reduce misdiagnoses among hypercapnic patients.
